These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27411725)

  • 21. The efficiency of potassium removal during bicarbonate hemodialysis.
    Capdevila M; Ruiz IM; Ferrer C; Monllor F; Ludjvick C; García NH; Juncos LI
    Hemodial Int; 2005 Jul; 9(3):296-302. PubMed ID: 16191080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personal preparation of bicarbonate solutions--cost comparison and quality control].
    Kaiser W; Biesenbach G; Kramer E; Dunzinger I; Zazgornik J
    Wien Klin Wochenschr; 1988 Nov; 100(22):733-6. PubMed ID: 3239069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of bicarbonate dialysis during CAVHD.
    Jenkins RD; Jackson E; Kuhn R; Funk J
    ASAIO Trans; 1990; 36(3):M465-6. PubMed ID: 2252728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The choice of dialysate bicarbonate: do different concentrations make a difference?
    Basile C; Rossi L; Lomonte C
    Kidney Int; 2016 May; 89(5):1008-1015. PubMed ID: 26924048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D; Knoll G
    Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of acidosis and nutritional parameters in hemodialysis patients.
    Uribarri J; Levin NW; Delmez J; Depner TA; Ornt D; Owen W; Yan G
    Am J Kidney Dis; 1999 Sep; 34(3):493-9. PubMed ID: 10469860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citric Acid-Containing Dialysate and Survival Rate in the Dialysis Outcomes and Practice Patterns Study.
    Ureña-Torres P; Bieber B; Guebre-Egziabher F; Ossman R; Jadoul M; Inaba M; Robinson BM; Port F; Jacquelinet C; Combe C
    Kidney360; 2021 Apr; 2(4):666-673. PubMed ID: 35373053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic acidosis in hemodialysis patients: a study of prevalence and factors affecting intradialytic bicarbonate gain.
    Sepandj F; Jindal K; Kiberd B; Hirsch D
    Artif Organs; 1996 Sep; 20(9):976-80. PubMed ID: 8864017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of hemodialysis associated hypoxemia by use of low-concentration bicarbonate dialysate.
    Ganss R; Aarseth HP; Nordby G
    ASAIO J; 1992; 38(4):820-2. PubMed ID: 1450479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and analytical changes in hemodialysis without acetate].
    Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
    Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
    Thaha M; Yogiantoro M; Soewanto ; Pranawa
    Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients.
    Yamamoto T; Shoji S; Yamakawa T; Wada A; Suzuki K; Iseki K; Tsubakihara Y
    Am J Kidney Dis; 2015 Sep; 66(3):469-78. PubMed ID: 26015276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
    Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
    Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Plasma acetate and bicarbonate kinetics and intolerance to acetate during and after renal dialysis].
    Bruno R; Grandvuillemin M; Olmer M; Cano JP
    Pathol Biol (Paris); 1984 Sep; 32(7):768-71. PubMed ID: 6493812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferred dialysis fluid for the high-performance membrane.
    Tomo T
    Contrib Nephrol; 2011; 173():44-52. PubMed ID: 21865775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Will there be acetate in dialysis solutions for the foreseeable future?].
    Bolasco P; Panichi V; Paletti S; Mancini E
    G Ital Nefrol; 2011; 28(4):359-68. PubMed ID: 21809305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of acetate and bicarbonate on the tolerance for hemodialysis therapy in chronic kidney failure].
    Shostka GD; T'iagi S; Kulikova AI; Spiridonov VN; Kostkina MI; Vitenberg AG
    Urol Nefrol (Mosk); 1990; (6):39-44. PubMed ID: 2089765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic modeling of intradialytic and interdialytic pH shifts during and after acetate and bicarbonate hemodialysis.
    Monti JP; Sarrazin MY; Baz M; Murisasco A; Crevat AD; Elsen R
    Artif Organs; 1990 Jun; 14(3):191-5. PubMed ID: 2357144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodialysis dose and serum bicarbonate (chapter 7).
    Tomson C; Thomas D; Rao R; van Schalkwyk D; Ansell D
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii69-77. PubMed ID: 17724053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.